Format

Send to

Choose Destination
Lancet Oncol. 2015 Aug;16(8):e373-4. doi: 10.1016/S1470-2045(15)00145-X.

Surgery versus SABR for resectable non-small-cell lung cancer.

Author information

1
Department of Medical Sciences, University of Oxford, Oxford, UK.
2
Radiotherapy Department, Royal Marsden Hospital and the Institute of Cancer Research, London, UK.
3
St James's Institute of Oncology, Leeds Cancer Centre, St James's University Teaching Hospital, UK.
4
The Christie NHS Foundation Trust, Manchester, UK.
5
National Institute for Health Research Oxford Biomedical Research Centre, Cancer Research UK, University of Oxford, OX3 7DQ, Oxford, UK; Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, OX3 7DQ, Oxford, UK. Electronic address: ricky.sharma@oncology.ox.ac.uk.
PMID:
26248840
DOI:
10.1016/S1470-2045(15)00145-X
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center